tiprankstipranks
Trending News
More News >

Checkpoint Therapeutics Enhances Board with New Independent Director

Confident Investing Starts Here:

An update from Checkpoint Therapeutics Inc (CKPT) is now available.

Checkpoint Therapeutics, Inc. has strengthened its corporate governance by appointing Dr. Amit Sharma to its Board of Directors, effectively addressing a previous deficiency with Nasdaq’s independence requirements. Dr. Sharma, with no disclosed conflicts of interest, will serve until the next annual meeting where stockholders will have a chance to elect him. His addition signifies a commitment to independent oversight, a key factor for investor confidence in the integrity of the company’s management.

For detailed information about CKPT stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App